An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis
Author(s) -
Ben Roediger,
Quintin Lee,
Shweta Tikoo,
Joanna C. A. Cobbin,
James M. Henderson,
Mika Jormakka,
Matthew B. O’Rourke,
Matthew P. Padula,
Natalia Pinello,
Marisa Henry,
Maria Wynne,
Sara Francesca Santagostino,
Cory Brayton,
Lorna Rasmussen,
Leszek Lisowski,
Szun S. Tay,
David C.H. Harris,
John F. Bertram,
John P. Dowling,
Patrick Bertolino,
Jack H. Lai,
Wengen Wu,
William W. Bachovchin,
Justin Wong,
Mark D. Gorrell,
Babak Shaban,
Edward C. Holmes,
Christopher J. Jolly,
Sébastien Monette,
Wolfgang Weninger
Publication year - 2018
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2018.08.013
Subject(s) - biology , parvovirus , kidney disease , nephropathy , fibrosis , kidney , pathology , immunology , renal pathology , virus , genetics , medicine , endocrinology , diabetes mellitus
The occurrence of a spontaneous nephropathy with intranuclear inclusions in laboratory mice has puzzled pathologists for over 4 decades, because its etiology remains elusive. The condition is more severe in immunodeficient animals, suggesting an infectious cause. Using metagenomics, we identify the causative agent as an atypical virus, termed "mouse kidney parvovirus" (MKPV), belonging to a divergent genus of Parvoviridae. MKPV was identified in animal facilities in Australia and North America, is transmitted via a fecal-oral or urinary-oral route, and is controlled by the adaptive immune system. Detailed analysis of the clinical course and histopathological features demonstrated a stepwise progression of pathology ranging from sporadic tubular inclusions to tubular degeneration and interstitial fibrosis and culminating in renal failure. In summary, we identify a widely distributed pathogen in laboratory mice and establish MKPV-induced nephropathy as a new tool for elucidating mechanisms of tubulointerstitial fibrosis that shares molecular features with chronic kidney disease in humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom